• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Jules Fabre
Jules Fabre
Jules Fabre

Jules Fabre

Taylor Wessing

Partner

  • Paris France
Contact Me Today
+33 1 72 74 03 33
vCard
Email me Call me
Featured award

IAM Patent 1000 2025

Silver Individuals : Litigation - "Jules is a genius from a legal and strategic standpoint. He can take on critical and complicated litigation projects, demonstrating his high level of organisation, diligence and ability to be on top of every detail in the case. Jules has a great understanding of the technical aspects as well as the law, and utilises this to provide excellent insight, tactical advice and superb advocacy. He is totally unpretentious, approachable, amiable and an overall joy to work with."

Scroll to featured award

Jules Fabre heads Taylor Wessing's patent department in Paris. He specialises in intellectual property, with a particular focus on patent and regulatory matters in the Life Sciences and pharmaceutical sector.

He has extensive experience handling complex French and cross border patent and SPC litigations, both in private practice and in­house and is often instructed by clients to handle the pan-European co-ordination of their patent litigations and market access strategies, in addition to representing them before French courts and the UPC. Jules was involved in the first ever branded versus generic patent litigation brought before the UPC.

ln addition to his previous experience in other international law firms (Hogan Lovells, Linklaters, Pinsent Masons), Jules was a Senior Counsel in the European IP and Regulatory Litigation team of a Teva Pharmaceuticals in London, where he coordinated pan-European launch strategies, patent litigations and settlements. This brings an in-depth understanding of the industry from the inside, which enables Jules to provide sound and commercially relevant advice, and a detailed knowledge of patent litigation in the various European jurisdictions.

Jules is Unified Patent Court (UPC) representative.

Expertise

Services and Groups

Patents & innovation
Resolving patents & know-how disputes
Drafting and negotiating patents & know-how commercial agreements

Sectors

Automotive & mobility
Manufacturing & industrials
Chemicals
Life sciences & healthcare

Patent Perspective Quick Listens

A UPC and European patent litigation podcast.

Listen now

CV

Since 2025 Partner, Taylor Wessing
2023 - 2025 Partner, Pinsent Masons
2019 - 2023 Counsel, Pinsent Masons
2017 - 2019 Senior Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals in London
2014 – 2017 Senior Associate, Linklaters
2011 – 2014 Associate, Hogan Lovells
2012 Admitted to the Bar, Paris
2008 Master II Droit de la Propriété Intellectuelle, Concurrence, Distribution et Commerce, Centre d’Études Internationales de la Propriété Intellectuelle (Strasbourg)

Career

Since 2025 Partner, Taylor Wessing
2023 - 2025 Partner, Pinsent Masons
2019 - 2023 Counsel, Pinsent Masons
2017 - 2019 Senior Counsel, European IP and Regulatory Litigation, Teva Pharmaceuticals in London
2014 – 2017 Senior Associate, Linklaters
2011 – 2014 Associate, Hogan Lovells

Education

2012 Admitted to the Bar, Paris
2008 Master II Droit de la Propriété Intellectuelle, Concurrence, Distribution et Commerce, Centre d’Études Internationales de la Propriété Intellectuelle (Strasbourg)

Additional languages

English

Awards

IAM Patent 1000 2025

Featured

Silver Individuals : Litigation - "Jules is a genius from a legal and strategic standpoint. He can take on critical and complicated litigation projects, demonstrating his high level of organisation, diligence and ability to be on top of every detail in the case. Jules has a great understanding of the technical aspects as well as the law, and utilises this to provide excellent insight, tactical advice and superb advocacy. He is totally unpretentious, approachable, amiable and an overall joy to work with."

IP Stars 2025

Patent Star

Chambers & Partners France 2025

Intellectual Property: Patents - "Jules is proficient and very good, with a good technical background. He is absolutely outstanding and has a deep knowledge of the French system, the law and the practice."

JUVE Patent

Recommended individuals - “very happy with his work, he is a rising star”

Pharma/Life Sciences: Intellectual Property - "He is a brilliant intellectual property lawyer. I have learnt so much from him. He is really a great person and is assisting clients with a lot of care and oversight."

Healthcare life sciences - "Jules Fabre is a star in patent litigation in France. He has an extremely high level of expertise in this area and is a pleasure to work with."

Intellectual Property: Patents : ‘Jules Fabre, Marina Jonon: in addition to their outstanding knowledge of the technical area and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios, and achieved a major victory in a pharma patent action being litigated across Europe. ’

Jules's news & insights

View Jules's insights
UPC
Click here to find out more
UPC

Security for Costs before the Unified Patent Court (UPC) Current Case Law and Strategic Implications

7 November 2025

by multiple authors

Glass.Mapper.Sc.Fields.Image?.Alt
Patents & innovation

Preliminary injunctions in France

22 October 2025
Briefing

by multiple authors

Click here to find out more
Open podcast
Patent Perspectives Quick Listens

Episode 10 - Marking the second anniversary of the UPC

In episode ten of Patent Perspectives, Paul England is joined by Amanda Ebbutt, Christian Dekoninck, Jules Fabre and Phillip Rektorschek.

9 June 2025

by multiple authors

English

1 of 10 Podcasts

Click here to find out more
View Jules's insights

Related news & insights

Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Patterned pills
Life sciences & healthcare

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

23 January 2026
Briefing

by Irina Rebin and Daniel Dietrich

Click here to find out more
Low Angle View Of Flags Waving
Logistics & transport

EU Inc.: Founders and companies with expansion plans must now think strategically

23 January 2026
Quick read

by Dr. Benedikt Groh and Fritz Krings

Click here to find out more
Office facade reflection
Life sciences & healthcare

Advising Nuclera on its extended Series C funding to US$87 million

22 January 2026

by Ross McNaughton and Oli Denne

Click here to find out more
Windows of modern futuristic glass
Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part one

21 January 2026
In-depth analysis

by multiple authors

Click here to find out more
Low angle view of futuristic skyscrapers
Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part two

21 January 2026
In-depth analysis

by multiple authors

Click here to find out more
UPC

Territorial Scope of UPC Decisions under Article 34 UPCA: Recent Case Law, Interpretative Trends and Strategic Implications

15 January 2026
Briefing

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Voltatron AG on the acquisition of Komitec Electronics GmbH

15 January 2026

by multiple authors

Click here to find out more

Update from Berlin: Federal government tightens cannabis policy

8 January 2026
Briefing

by Kathleen Munstermann-Senff, LL.M. (Medical Law) and Dr. Martin Jäger

Click here to find out more
View all insights

Related people

France
/Taylor Wessing/Images/People/Profiles/France/Jonon-Marina/Jonon-Marina-wit

Marina Jonon

Counsel

Paris
+33 1 72 74 03 33
Email me
View profile
/Taylor Wessing/Images/People/Profiles/France/Millot-Louise/Millot-Louise-wit

Louise Millot

Associate

Paris
+33 1 72 74 03 33
Email me
View profile
Clémence de Marassé-Enouf

Clémence de Marassé-Enouf

Associate

Paris
+33 1 72 74 03 33
Email me
View profile
Person Placeholder Image

Lucile Cheneau

Associate

Paris
+33 1 72 74 03 33
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing